Delcath Systems (NASDAQ:DCTH) is one of today's best performing penny stocks, up 5.9% to $0.50 on 1.0x average daily volume. Thus far today, Delcath Systems has traded 2.6 million shares, vs. average volume of 2.5 million shares per day. The stock has outperformed the Dow (6.0% to the Dow's -0.6%) and outperformed the S&P 500 (6.0% to the S&P's -0.5%) during today's trading.
In the past 52 weeks, shares of Delcath Systems have traded between a low of $0.38 and a high of $9.70 and are now at $0.50, which is 33% above that low price. Over the past week, the 200-day moving average (MA) has gone down 2.1% while the 50-day MA has declined 11.9%.
Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment.
Delcath Systems (NASDAQ:DCTH) is currently priced 19.7% above its average consensus analyst price target of $0.40. Delcath Systems shares should first meet resistance at the 50-day moving average (MA) of $0.84 and find additional resistance at the 200-day MA of $1.40.